Alain Bols

1.4k total citations
23 papers, 394 citations indexed

About

Alain Bols is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alain Bols has authored 23 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alain Bols's work include Colorectal and Anal Carcinomas (5 papers), Medical Imaging Techniques and Applications (2 papers) and DNA Repair Mechanisms (2 papers). Alain Bols is often cited by papers focused on Colorectal and Anal Carcinomas (5 papers), Medical Imaging Techniques and Applications (2 papers) and DNA Repair Mechanisms (2 papers). Alain Bols collaborates with scholars based in Belgium, United Kingdom and Spain. Alain Bols's co-authors include Kenneth Coenegrachts, Marc Haspeslagh, David Volders, H.W. Van Landuyt, Eric Nulens, Barbara Bussels, B. Gordts, Marc Peeters, Pieter Demetter and Frank Speleman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Radiology.

In The Last Decade

Alain Bols

22 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alain Bols Belgium	10	137	116	78	78	73	23	394
Ying-Hao Wen Taiwan	11	37 0.3×	65 0.6×	24 0.3×	25 0.3×	43 0.6×	32	386
Meenal Sharma India	14	22 0.2×	118 1.0×	8 0.1×	106 1.4×	92 1.3×	33	554
Harry R. Gibbs United States	10	86 0.6×	172 1.5×	8 0.1×	46 0.6×	55 0.8×	23	394
Adam J. Bograd United States	14	139 1.0×	286 2.5×	78 1.0×	528 6.8×	156 2.1×	45	853
G. Ronchi Italy	13	163 1.2×	56 0.5×	69 0.9×	68 0.9×	261 3.6×	37	1.6k
Takashi Hanada Japan	15	91 0.7×	34 0.3×	44 0.6×	191 2.4×	74 1.0×	67	529
Elise Toussaint France	7	45 0.3×	97 0.8×	10 0.1×	32 0.4×	17 0.2×	14	245
Kandice Knigge United States	11	86 0.6×	259 2.2×	13 0.2×	154 2.0×	222 3.0×	18	821
Aranzazu Jauregui-Amezaga Spain	13	54 0.4×	77 0.7×	16 0.2×	32 0.4×	461 6.3×	31	1.1k
Marije K. Verheul Netherlands	16	343 2.5×	47 0.4×	5 0.1×	56 0.7×	24 0.3×	38	900

Countries citing papers authored by Alain Bols

Since Specialization

Citations

This map shows the geographic impact of Alain Bols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Bols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Bols more than expected).

Fields of papers citing papers by Alain Bols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Bols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Bols. The network helps show where Alain Bols may publish in the future.

Co-authorship network of co-authors of Alain Bols

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Bols. A scholar is included among the top collaborators of Alain Bols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Bols. Alain Bols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Metcalf, Robert L., Simon Laban, T-E. Ciuleanu, et al.. (2024). VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study. Annals of Oncology. 35(8). 754–755. 1 indexed citations

2.

Joris, Sofie, Hannelore Denys, Daphné t’Kint de Roodenbeke, et al.. (2021). 88P Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study. Annals of Oncology. 32. S394–S394. 1 indexed citations

3.

Piessevaux, Hubert, Wim Demey, Alain Bols, et al.. (2018). Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (MAGNET trial). Annals of Oncology. 29. viii640–viii640. 1 indexed citations

4.

Almhanna, Khaldoun, David Wright, T. Macarulla Mercadé, et al.. (2017). A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C. Investigational New Drugs. 35(5). 634–641. 31 indexed citations

5.

Vlayen, Joan, Jo Robays, Sabine Stordeur, et al.. (2017). Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?. Critical Reviews in Oncology/Hematology. 114. 43–52. 32 indexed citations

6.

Bols, Alain, et al.. (2017). Extraosseous Ewing’s sarcoma, a case report on a rare diagnosis in an 80-year-old woman with a large abdominal mass. South African Journal of Radiology. 21(1). 1 indexed citations

7.

Cutsem, Eric Van, Didier Bielen, Alain Bols, et al.. (2016). Guideline on the management of rectal cancer. 1 indexed citations

8.

Bols, Alain, et al.. (2016). Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study. Cancer Management and Research. 8. 1–1. 9 indexed citations

9.

Almhanna, Khaldoun, David Wright, T. Macarulla Mercadé, et al.. (2016). Abstract CT117: A phase II trial of TAK-264, a novel antibody-drug conjugate (ADC), in patients with pancreatic adenocarcinoma expressing guanylyl cyclase C (GCC). Cancer Research. 76(14_Supplement). CT117–CT117. 1 indexed citations

10.

Vermassen, Tijl, Denis Schallier, Jean-Pascal Machiels, et al.. (2014). Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium. Acta Clinica Belgica. 69(5). 335–340. 2 indexed citations

11.

Volders, David, Alain Bols, Marc Haspeslagh, & Kenneth Coenegrachts. (2013). Model-based Iterative Reconstruction and Adaptive Statistical Iterative Reconstruction Techniques in Abdominal CT: Comparison of Image Quality in the Detection of Colorectal Liver Metastases. Radiology. 269(2). 469–474. 91 indexed citations

12.

Volders, David, Alain Bols, Marc Haspeslagh, & Kenneth Coenegrachts. (2013). Model-based Iterative Reconstruction and Adaptive Statistical Iterative Reconstruction Techniques in Abdominal CT: Comparison of Image Quality in the Detection of Colorectal Liver Metastases. Radiology. 269(2). 469–474. 2 indexed citations

13.

Coenegrachts, Kenneth, Alain Bols, Marc Haspeslagh, & H. Rigauts. (2012). Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: Potential of whole tumour ROI and selective ROI analysis. European Journal of Radiology. 81(12). 3870–3876. 26 indexed citations

14.

Leeneer, Kim De, Ilse Coene, Rudy Van den Broecke, et al.. (2011). Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing. Breast Cancer Research and Treatment. 132(1). 87–95. 25 indexed citations

15.

Damme, Nancy Van, Philippe Deron, Nadine Van Roy, et al.. (2010). Epidermal Growth Factor Receptor and K-RAS status in two cohorts of squamous cell carcinomas. BMC Cancer. 10(1). 189–189. 64 indexed citations

16.

Pronzato, P., Enrico Cortesi, Carin C.D. van der Rijt, et al.. (2010). Epoetin Alfa Improves Anemia and Anemia-Related, Patient-Reported Outcomes in Patients with Breast Cancer Receiving Myelotoxic Chemotherapy: Results of a European, Multicenter, Randomized, Controlled Trial. The Oncologist. 15(9). 935–943. 22 indexed citations

17.

Damme, Nele Van, et al.. (2008). EGFR and K-RAS gene status evaluation in anal canal squamous cell carcinoma. Journal of Clinical Oncology. 26(15_suppl). 15569–15569. 5 indexed citations

18.

Lomax, Antony, Francesca Albertini, T. Boehringer, et al.. (2006). 58 Spot scanning proton therapy: Treatment planning and treatment verification. Radiotherapy and Oncology. 78. S21–S21. 3 indexed citations

19.

Nulens, Eric, Barbara Bussels, Alain Bols, B. Gordts, & H.W. Van Landuyt. (2001). Recurrent bacteremia by Chtyseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clinical Microbiology and Infection. 7(7). 391–393. 57 indexed citations

20.

Bols, Alain, André Nevelsteen, & Raymond Verhaeghe. (1994). Atheromatous embolization precipitated by oral anticoagulants.. PubMed. 13(3). 271–4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact